Diagnosis and Risk Assessment in Neuroblastoma: Current Evidence and a Pilot Retrospective Study
: Background: Neuroblastoma (NB) is a heterogeneous pediatric malignancy requiring accurate risk stratification. This study explored the relationship between conventional biomarkers and disease characteristics in a pediatric NB cohort and contextualized these findings with emerging evidence on non-coding RNA (ncRNA) bi...